Holen Sie sich die Stockscreener-App
2.83
5.67%
-0.17
Handel nachbörslich:
2.85
0.02
+0.71%
Schlusskurs vom Vortag:
$3.00
Offen:
$3.02
24-Stunden-Volumen:
989.52K
Relative Volume:
4.10
Marktkapitalisierung:
$76.22M
Einnahmen:
$247.99M
Nettoeinkommen (Verlust:
$-521.97M
KGV:
-3.9306
EPS:
-0.72
Netto-Cashflow:
$-194.28M
1W Leistung:
-38.61%
1M Leistung:
-42.36%
6M Leistung:
-75.89%
1J Leistung:
-83.35%
1-Tages-Spanne:
$2.75
$3.15
1-Wochen-Bereich:
$2.75
$5.348
52-Wochen-Spanne:
$2.75
$20.40
23 Andme Holding Co Stock (ME) Company Profile
Firmenname
23 Andme Holding Co
Sektor
Branche
Telefon
(650) 938-6300
Adresse
223 N. MATHILDA AVE., SUNNYVALE
Vergleichen Sie ME mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
| ME | 2.83 | 76.22M | 247.99M | -521.97M | -194.28M | -0.72 |
| TMO | 501.29 | 192.46B | 42.37B | 6.14B | 7.78B | 15.26 |
| DHR | 230.06 | 166.23B | 23.74B | 3.89B | 4.98B | 7.93 |
| A | 126.92 | 36.47B | 6.50B | 1.41B | 1.42B | 3.82 |
| IQV | 191.04 | 34.67B | 15.32B | 1.41B | 1.96B | 5.95 |
| IDXX | 419.83 | 34.38B | 3.84B | 866.24M | 792.60M | 9.80 |
23 Andme Holding Co Stock (ME) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2022-11-29 | Eingeleitet | Berenberg | Buy |
| 2022-09-22 | Eingeleitet | Cowen | Outperform |
| 2021-11-15 | Herabstufung | Citigroup | Buy → Neutral |
| 2021-08-17 | Eingeleitet | Credit Suisse | Outperform |
| 2021-07-12 | Eingeleitet | Citigroup | Buy |
23 Andme Holding Co Aktie (ME) Neueste Nachrichten
23andMe to slash 40% of its workforce, end therapeutics program to cut costs - MSN
Earnings call: 23andMe announces restructuring and focus shift By Investing.com - Investing.com Australia
23andMe Holding Co. (NASDAQ:ME) Q2 2025 Earnings Call Transcript - Insider Monkey
23andMe Reports Improved Financial Metrics Amid Revenue Decline - TipRanks
Earnings call: 23andMe announces restructuring and focus shift - Investing.com India
23Andme Holding Co earnings missed by $2.16, revenue topped estimates - Investing.com Canada
23andMe cuts 40% of its workforce - Fox Business
Struggling Genetic Testing Company 23andMe To Lay Off 40% Of Its Workforce, Discontinues All Therapeutic Programs - Yahoo Finance UK
23andMe’s stock turns lower after company posts its latest quarterly loss - MSN
23andMe cuts 40% of its workforce, discontinues all therapy programs - Reuters
23andMe to Explore Strategic Alternatives - Marketscreener.com
23andMe Holding Co Reports Q2 FY25 Revenue of $44 Million, Missi - GuruFocus.com
23andMe Holding Co. (ME) Misses Q2 EPS by 216c - StreetInsider.com
23andMe Reports Second Quarter Fiscal Year 2025 Financial Results - GlobeNewswire
23andMe Holding Co. Announces Reduce Overall Headcount - Marketscreener.com
23andMe Holding Co. (ME) Quarterly 10-Q Report - Quartzy
23andMe Announces Business Restructuring to Streamline Operations, Reduce Costs and Position Company for the Future - The Manila Times
23andMe Announces Business Restructuring to Streamline - GlobeNewswire
23andMe Cuts 40% of Workforce, Exits Therapeutics in Major Cost-Saving Overhaul | ME Stock News - StockTitan
Earnings Outlook For 23andMe Holding - Benzinga
Federal law could prevent your 23andMe data deletion, but you should still try - Android Police
CORRECTION23andMe to Report Q2 FY2025 Financial Results - The Manila Times
23andMe Revises Q2 FY2025 Earnings Release Time to Pre-Market on Nov 12 | ME Stock News - StockTitan
23andMe to Report Q2 FY2025 Financial Results - The Manila Times
23andMe Sets Q2 FY2025 Earnings Call for November 12: What Investors Need to Know | ME Stock News - StockTitan
Vanguard Group's Strategic Acquisition of 23andMe Shares - GuruFocus.com
23andMe turns to CFOs to fill director roles after mass board exit - Yahoo Finance
23andMe regains Nasdaq compliance, avoids delisting By Investing.com - Investing.com Australia
23andMe regains Nasdaq compliance, avoids delisting - Investing.com
23andMe Regains Nasdaq Compliance and Ensures Listing - TipRanks
23andMe Regains Compliance With Nasdaq Listing Requirements - The Manila Times
23andMe Stock Price Prediction: 2024, 2025, 2030 - Benzinga
23andMe Holding Expands Board with New Appointments - TipRanks
23andMe expands board with three new directors - Investing.com
23andMe Appoints Three New Independent Directors to Board - The Manila Times
23andMe expands board with three new directors By Investing.com - Investing.com UK
23andMe Holding Co. (ME) Appoints Andre Fernandez, Jim Frankola, and Mark Jensen to its Board - StreetInsider.com
BANKRUPTCY THREAT: How KY & IN 23andMe Clients Can Protect Themselves - WBKR
US Judge OKs $110 Million Settlements in Antitrust Case Against Major Real Estate Brokerages - PYMNTS.com
Ancestry Says a 23AndMe Takeover Would Raise Antitrust Issues - Bloomberg
23andMe: Liquidity Pressures And Operational Instability Pose Significant Risks - Seeking Alpha
Wojcicki ‘Committed’ to Taking 23andMe Private as Board Quits - MSN
23andMe Holding Co. (NASDAQ:ME) Sees Large Decline in Short Interest - MarketBeat
23andMe Holding Co. (ME) Stock Price, News, Quote & History - Yahoo Finance
23andMe (NASDAQ:ME) Sets New 1-Year LowHere's Why - MarketBeat
Once worth $6 billion, why is the biology company 23andMe on the brink of bankruptcy? - vietnam.vn
SC US (TTGP), LTD. Acquires New Stake in 23andMe Holding Co - GuruFocus.com
Avoid This Former High-Flying Stock Split Stock at All Costs - 24/7 Wall St.
Finanzdaten der 23 Andme Holding Co-Aktie (ME)
Umsatz
Nettogewinn
Free Cashflow
ENV
5.04%
3.19%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):